| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc2b03342511abc88f60c63f2acd96d0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-10001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate |
2011-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf25024f424700965bdfd7ad8dc67e84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb1e679b25bb1f02388f553cc0614597
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0105e44d426ed8e0d0183daa20b512b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff2e67591cb625ed35e9304c60937699
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48fc7fd2cc3a197622b787b178fba47b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4e9aad90ff8a187b7f38ef5cc45d7f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5280186c7c647803ae746a13b83db89 |
| publicationDate |
2017-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
PT-2525824-T |
| titleOfInvention |
INHIBITION OF AXL SIGNALING IN ANTIMETASTACTIC THERAPY |
| priorityDate |
2010-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |